Avalo Therapeutics (AVTX) Free Cash Flow (2014 - 2026)
Avalo Therapeutics posted quarterly Free Cash Flow of -$17.7 million for Q1 2026, down 87.16% year-on-year from -$137.9 million in Q1 2025, and down 23.88% on a QoQ basis from -$14.3 million in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Free Cash Flow data on file, last reported at -$17.7 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 87.16% year-over-year to -$17.7 million; the trailing twelve-month figure through Mar 2026 stood at -$59.7 million (down 14.21% YoY), and the FY2025 full-year result was -$51.5 million, down 4.98% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$17.7 million, down from -$14.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.7 million in Q3 2022 and bottomed at -$17.7 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$11.4 million (2025), against an average of -$10.3 million.
- The widest annual swing landed in 2022, when Free Cash Flow surged 134.74%; it then sank 443.89% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$3.8 million in 2022, then rose by 28.06% to -$2.8 million in 2023, then tumbled by 443.89% to -$15.0 million in 2024, then grew by 5.03% to -$14.3 million in 2025, then retreated by 23.88% to -$17.7 million in 2026.
- The last three Free Cash Flow figures came in at -$17.7 million (Q1 2026), -$14.3 million (Q4 2025), and -$16.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | -17.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.70 Mn |
| Mar 31, 2026 | -17.70 Mn |
| Dec 31, 2025 | -14.29 Mn |
| Dec 31, 2025 | -14.29 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Dec 31, 2024 | -15.04 Mn |
| Dec 31, 2024 | -15.04 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Sep 30, 2023 | -6.84 Mn |
| Sep 30, 2023 | -6.84 Mn |
| Jun 30, 2023 | -11.03 Mn |
| Jun 30, 2023 | -11.03 Mn |
| Mar 31, 2023 | -10.21 Mn |
| Mar 31, 2023 | -10.21 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | -12.53 Mn |
| Jun 30, 2022 | -12.53 Mn |
| Mar 31, 2022 | -16.07 Mn |
| Mar 31, 2022 | -16.07 Mn |
| Dec 31, 2021 | -17.11 Mn |
| Dec 31, 2021 | -17.11 Mn |
| Sep 30, 2021 | -16.37 Mn |
| Sep 30, 2021 | -16.37 Mn |
| Jun 30, 2021 | -19.19 Mn |
| Jun 30, 2021 | -19.19 Mn |
| Mar 31, 2021 | -18.34 Mn |
| Mar 31, 2021 | -18.34 Mn |
| Dec 31, 2020 | -14.38 Mn |
| Dec 31, 2020 | -14.38 Mn |
| Sep 30, 2020 | -11.93 Mn |
| Sep 30, 2020 | -11.93 Mn |
| Jun 30, 2020 | -8.56 Mn |
| Jun 30, 2020 | -8.56 Mn |
| Mar 31, 2020 | -5.74 Mn |
| Mar 31, 2020 | -5.74 Mn |
| Dec 31, 2019 | -1.68 Mn |
| Dec 31, 2019 | -1.68 Mn |
| Sep 30, 2019 | -7.62 Mn |
| Sep 30, 2019 | -7.62 Mn |
| Jun 30, 2019 | -6.81 Mn |
| Jun 30, 2019 | -6.81 Mn |
| Mar 31, 2019 | -3.29 Mn |
| Mar 31, 2019 | -3.29 Mn |
| Dec 31, 2018 | -2.48 Mn |
| Dec 31, 2018 | -2.48 Mn |
| Sep 30, 2018 | -577,476.00 |
| Sep 30, 2018 | -577,476.00 |
| Jun 30, 2018 | -340,380.00 |
| Jun 30, 2018 | -340,380.00 |
| Mar 31, 2018 | -299,647.00 |
| Mar 31, 2018 | -299,647.00 |
| Dec 31, 2017 | -2.56 Mn |
| Dec 31, 2017 | -2.56 Mn |
| Sep 30, 2017 | 19.12 Mn |
| Sep 30, 2017 | 19.12 Mn |
| Jun 30, 2017 | -1.76 Mn |
| Jun 30, 2017 | -1.76 Mn |
| Mar 31, 2017 | -2.24 Mn |
| Mar 31, 2017 | -2.24 Mn |
| Dec 31, 2016 | -3.72 Mn |
| Dec 31, 2016 | -3.72 Mn |
| Sep 30, 2016 | -3.44 Mn |
| Sep 30, 2016 | -3.44 Mn |
| Jun 30, 2016 | -3.73 Mn |
| Jun 30, 2016 | -3.73 Mn |
| Mar 31, 2016 | -3.72 Mn |
| Mar 31, 2016 | -3.72 Mn |
| Dec 31, 2015 | -3.55 Mn |
| Dec 31, 2015 | -3.55 Mn |
| Sep 30, 2015 | -1.81 Mn |
| Sep 30, 2015 | -1.81 Mn |
| Jun 30, 2015 | -1.73 Mn |
| Jun 30, 2015 | -1.73 Mn |
| Mar 31, 2015 | -3.07 Mn |
| Mar 31, 2015 | -3.07 Mn |
| Dec 31, 2014 | -3.97 Mn |
| Dec 31, 2014 | -3.97 Mn |